Cryoport, Inc. (CYRX) stock
CYRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/3025% above fair value
$19.89−0.21 (-1.04%)
Close on Nov 13, 2026Market cap $1.01BP/E –Yield –
Cryoport profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Cryoport's profit margin for the twelve months ending Sep 30, 2026 was -21.5%. For fiscal 2025 it was 44.4%, against -73.2% the year before. The highest annual figure on record is 44.4% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 44.4% | +117.6 |
| FY2024 | Dec 31, 2024 | -73.2% | −14.2 |
| FY2023 | Dec 31, 2023 | -59.0% | −43.3 |
| FY2022 | Dec 31, 2022 | -15.7% | +108.0 |
| FY2021 | Dec 31, 2021 | -123.8% | −82.2 |
| FY2020 | Dec 31, 2020 | -41.5% | +12.5 |
| FY2019 | Dec 31, 2019 | -54.0% | −5.3 |
| FY2018 | Dec 31, 2018 | -48.7% | +118.3 |
| FY2016 | Mar 31, 2016 | -167.0% | +11.6 |
| FY2015 | Mar 31, 2015 | -178.6% | +557.0 |
| FY2014 | Mar 31, 2014 | -735.6% | −155.6 |
| FY2013 | Mar 31, 2013 | -579.9% | +829.8 |
| FY2012 | Mar 31, 2012 | -1409.7% | −115.9 |
| FY2011 | Mar 31, 2011 | -1293.8% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Sep 30, 2026 | -21.6% | −5.9 |
| Q2 FY2026CQ2 2026 | Jun 30, 2026 | -16.9% | −256.4 |
| Q1 FY2026CQ1 2026 | Mar 31, 2026 | -22.1% | +7.1 |
| Q4 FY2025CQ4 2025 | Dec 31, 2025 | -25.6% | +19.4 |
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | -15.7% | −17.8 |
| Q2 FY2025CQ2 2025 | Jun 30, 2025 | 239.5% | +435.9 |
| Q1 FY2025CQ1 2025 | Mar 31, 2025 | -29.2% | +21.5 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | -45.1% | +63.9 |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | 2.1% | +25.7 |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | -196.4% | −164.2 |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | -50.7% | −41.8 |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -109.0% | −93.3 |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -23.6% | −14.8 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -32.2% | −17.9 |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | -8.9% | +16.8 |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | -15.6% | +445.2 |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | -8.8% | +2.7 |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | -14.3% | −4.7 |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | -25.6% | −19.0 |
| Q4 FY2021CQ4 2021 | Dec 31, 2021 | -460.8% | −437.0 |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | -11.5% | +90.7 |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | -9.6% | +52.2 |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | -6.6% | +33.7 |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | -23.8% | −13.6 |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | -102.2% | +27.9 |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | -61.8% | −31.9 |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | -40.3% | −4.5 |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -10.3% | +29.4 |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -130.1% | −89.5 |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -29.9% | +23.5 |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -35.9% | +30.8 |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -39.7% | +165.9 |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -40.6% | +144.9 |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | -53.4% | +408.3 |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | -66.7% | +112.4 |
| Q3 FY2016CQ4 2015 | Dec 31, 2015 | -205.6% | – |
| Q2 FY2016CQ3 2015 | Sep 30, 2015 | -185.5% | – |
| Q1 FY2016CQ2 2015 | Jun 30, 2015 | -461.7% | – |
| Q4 FY2015CQ1 2015 | Mar 31, 2015 | -179.1% | – |
See a number that looks wrong?